Search Results - "Booth, Clare L."

Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based Highly Active Antiretroviral Therapy by Geretti, Anna Maria, Fox, Zoe V, Booth, Clare L, Smith, Colette J, Phillips, Andrew N, Johnson, Margaret, Li, Jin-Fen, Heneine, Walid, Johnson, Jeffrey A

“…BACKGROUND:There are conflicting data on the impact of low-frequency transmitted drug-resistant mutants on responses to first-line highly active antiretroviral…”
Get full text

Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure by Macartney, Malcolm J., Irish, Dianne, Bridge, Simon H., Garcia-Diaz, Ana, Booth, Clare L., McCormick, Adele L., Labbett, Wendy, Smith, Colette, Velazquez, Carmen, Tanwar, Sudeep, Trembling, Paul, Jacobs, Michael, Dusheiko, Geoff, Rosenberg, William, Haque, Tanzina

“…•The development of resistance is detected frequently in patients failing treatment.•Treatment failure is also linked to viral genotype.•IL28B genotype is an…”
Get full text

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection by Booth, Clare L., Geretti, Anna Maria

“…Transmission of drug-resistant HIV-1 variants from antiretroviral treatment-experienced persons has been documented to occur through multiple routes, including…”
Get full text

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing by Cozzi-Lepri, Alessandro, Noguera-Julian, Marc, Di Giallonardo, Francesca, Schuurman, Rob, Däumer, Martin, Aitken, Sue, Ceccherini-Silberstein, Francesca, D'Arminio Monforte, Antonella, Geretti, Anna Maria, Booth, Clare L, Kaiser, Rolf, Michalik, Claudia, Jansen, Klaus, Masquelier, Bernard, Bellecave, Pantxika, Kouyos, Roger D, Castro, Erika, Furrer, Hansjakob, Schultze, Anna, Günthard, Huldrych F, Brun-Vezinet, Francoise, Paredes, Roger, Metzner, Karin J

“…It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART. This…”
Get full text

Mannose-Binding Lectin Accelerates Complement Activation and Increases Serum Killing of Neisseria meningitidis Serogroup C by Jack, Dominic L., Jarvis, Gary A., Booth, Clare L., Turner, Malcolm W., Klein, Nigel J.

“…The capacity for different lipo-oligosaccharide (LOS) sialylation patterns of Neisseria meningitidis serogroup C to influence the binding and function of the…”
Get full text

Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection by Booth, Clare L., Garcia-Diaz, Ana M., Youle, Michael S., Johnson, Margaret A., Phillips, Andrew, Geretti, Anna Maria

“…Objectives To determine prevalence and predictors of antiretroviral drug resistance in newly diagnosed individuals with HIV-1 infection, using a systematic…”
Get full text

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA by Booth, Clare L, McCormick, Adele, Garcia-Diaz, Ana, Macartney, Malcolm, Youle, Michael, Johnson, Margaret, Webster, Daniel

Get full text

Mannose-blinding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C by Jack, Dominic L, Jarvis, Gary A, Booth, Clare L, Turner, Malcolm W, Klein, Nigel J

“…The capacity for different lipo-oligosaccharide (LOS) sialylation patterns of Neisseria meningitidis serogroup C to influence the binding and function of the…”
Get full text